|
CA2894511C
(en)
|
2012-12-11 |
2021-12-07 |
Albert Einstein College Of Medicine Of Yeshiva University |
Methods for high throughput receptor:ligand identification
|
|
CN121159719A
(zh)
|
2015-04-17 |
2025-12-19 |
高山免疫科学股份有限公司 |
具有可调的亲和力的免疫调节蛋白
|
|
US10273281B2
(en)
|
2015-11-02 |
2019-04-30 |
Five Prime Therapeutics, Inc. |
CD80 extracellular domain polypeptides and their use in cancer treatment
|
|
WO2017181152A2
(en)
|
2016-04-15 |
2017-10-19 |
Alpine Immune Sciences, Inc. |
Cd80 variant immunomodulatory proteins and uses thereof
|
|
CN109689096A
(zh)
|
2016-05-18 |
2019-04-26 |
阿尔伯特爱因斯坦医学院公司 |
变体pd-l1多肽、t细胞调节性多聚体多肽及其使用方法
|
|
WO2017201210A1
(en)
|
2016-05-18 |
2017-11-23 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
ES2973548T3
(es)
|
2016-12-22 |
2024-06-20 |
Cue Biopharma Inc |
Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso
|
|
EP3565829A4
(en)
|
2017-01-09 |
2021-01-27 |
Cue Biopharma, Inc. |
T-CELL-MODULATING MULTIMERIC POLYPEPTIDES AND METHOD OF USING THEREOF
|
|
US20200010528A1
(en)
|
2017-03-15 |
2020-01-09 |
Cue Biopharma, Inc. |
Methods for modulating an immune response
|
|
SG11201907769XA
(en)
|
2017-03-16 |
2019-09-27 |
Alpine Immune Sciences Inc |
Cd80 variant immunomodulatory proteins and uses thereof
|
|
KR20190139216A
(ko)
|
2017-04-28 |
2019-12-17 |
파이브 프라임 테라퓨틱스, 인크. |
Cd80 세포외 도메인 폴리펩티드를 이용한 치료 방법
|
|
JP2020534352A
(ja)
*
|
2017-09-07 |
2020-11-26 |
キュー バイオファーマ，インコーポレーテッド |
コンジュゲーション部位を有するｔ細胞調節多量体ポリペプチド及びその使用方法
|
|
EP3678677A4
(en)
*
|
2017-09-07 |
2021-06-16 |
Cue Biopharma, Inc. |
Antigen-presenting polypeptides and methods of use thereof
|
|
CN111886241A
(zh)
|
2018-01-09 |
2020-11-03 |
库尔生物制药有限公司 |
多聚体t细胞调节多肽及其使用方法
|
|
EP3897690A4
(en)
*
|
2018-12-19 |
2022-09-28 |
Cue Biopharma, Inc. |
T LYMPHOCYTE MODULATOR MULTIMERIC POLYPEPTIDES HAVING CONJUGATION SITES AND METHODS OF USE THEREOF
|
|
US12589132B2
(en)
|
2019-02-22 |
2026-03-31 |
Five Prime Therapeutics, Inc. |
CD80 extracellular domain Fc fusion proteins for treating PD-L1 negative tumors
|
|
WO2020181272A1
(en)
*
|
2019-03-06 |
2020-09-10 |
Cue Biopharma, Inc. |
Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof
|
|
KR20220015382A
(ko)
*
|
2019-05-29 |
2022-02-08 |
큐 바이오파마, 인크. |
다량체 t-세포 조절 폴리펩타이드 및 이의 사용 방법
|
|
CA3146591A1
(en)
*
|
2019-09-20 |
2021-03-25 |
Ronald D. Seidel Iii |
T-cell modulatory polypeptides and methods of use thereof
|
|
DK4034170T3
(da)
|
2019-10-23 |
2026-03-30 |
Cue Biopharma Inc |
Tgf-beta-polypeptider
|
|
US20230126784A1
(en)
*
|
2020-03-06 |
2023-04-27 |
Albert Einstein College Of Medicine |
A method to generate chimeric antigen receptor (car) t-cells (car-t cells) from pathogen-specific cytotoxic lymphocytes to enable the subsequent in vivo modulation of their functional activity
|
|
EP4118105A2
(en)
*
|
2020-03-09 |
2023-01-18 |
Pfizer Inc. |
Cd80-fc fusion protein and uses thereof
|
|
WO2021231376A2
(en)
|
2020-05-12 |
2021-11-18 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
US20230218731A1
(en)
*
|
2020-05-26 |
2023-07-13 |
Cue Biopharma, Inc. |
Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
|
|
WO2021242935A1
(en)
*
|
2020-05-26 |
2021-12-02 |
Cue Biopharma, Inc. |
Antigen presenting polypeptide complexes and methods of use thereof
|
|
IL299834A
(en)
*
|
2020-07-14 |
2023-03-01 |
Cue Biopharma Inc |
with binding sites and methods for using them T - cellular modulatory polypeptides
|
|
WO2022056014A1
(en)
|
2020-09-09 |
2022-03-17 |
Cue Biopharma, Inc. |
Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof
|
|
CA3216273A1
(en)
*
|
2021-04-21 |
2022-10-27 |
Ronald D. SEIDEL III |
Antigen presenting polypeptide complexes bearing tgf-beta and methods of use thereof
|
|
WO2022251552A2
(en)
*
|
2021-05-26 |
2022-12-01 |
Cue Biopharma, Inc. |
Antigen presenting polypeptide complexes and methods of use thereof
|